Tirzepatide, a medication sold under the names Mounjaro for diabetes and Zepbound for weight loss, has shown impressive results in helping people avoid developing diabetes. A new study found that it ...

Novo Nordisk made a surprise bid for Metsera to boost its weight-loss market lead, trading at just 12x 2026 EPS. Read why NVO stock is a buy.

According to data published in Vogue Business more than 97 per cent of models in recent fashion weeks in London, Milan, Paris and New York, were judged to have 'very small' body types.

Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...

Novo Nordisk and Pfizer are showing some desperation in their gloves-off tussle for the obesity-drug assets of Metsera.

HELLO! Speaks to three board-certified surgeons, Dr Asif Pirani, Dr Raj Dedhia, and Dr Anthony Berlet to unpack the science ...

What exactly are GLP-1 drugs? Mounjaro and Zepbound, along with Ozempic and Wegovy, are part of a new wave of prescription ...

Just weeks ago, eshay influencer Spanian confirmed his split from wife Angela McColl, the mother of his baby son. He has since debuted his new relationship with a 22-year-old Sydney woman.

Television presenter Jeremy Clarkson has disclosed an awkward predicament at airport security stemming from his significant ...

Group agrees output hike of 137,000 bpd for Dec 2025; new sanctions make it difficult for Russia to raise output ...

Scripps Research in La Jolla announce a new clinical trial that will assess the effectiveness of using drugs approved for diabetes treatment and weight loss to treat long COVID-19, the debilitating ...